Sector Category: Life Sciences

Ventyx Biosciences
Developing selective inhibitors of TYK2 for autoimmune diseases.
Read More


ChromaCure
Focused on the development of a first-in-class oncology therapeutic.
Read More
NorthSea Therapeutics
Focused on the development of first-in-class therapeutics for NASH and other metabolic, inflammatory and fibrotic diseases.
Read More
Seahorse Bioscience
Acquired by Agilent Technologies. Developer of tools for measuring cell metabolism.
Read More

FlowCardia
Acquired by C.R. Bard. Developer of endovascular devices for the treatment of coronary and peripheral CTO.
Read More

Conor Medsystems
Acquired by Johnson & Johnson. Focused on the development of drug-eluting stents to treat coronary artery disease.
Read More